Page last updated: 2024-11-03

rimantadine and Lung Diseases, Obstructive

rimantadine has been researched along with Lung Diseases, Obstructive in 1 studies

Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.

Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.

Research Excerpts

ExcerptRelevanceReference
"Rimantadine was well-tolerated by the children, with no significant difference in reported adverse effects between the placebo and rimantadine groups."2.66Rimantadine prophylaxis in children: a follow-up study. ( Abell, TD; Clover, RD; Couch, RB; Crawford, SA; Glezen, P; Ramsey, CN, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crawford, SA1
Clover, RD1
Abell, TD1
Ramsey, CN1
Glezen, P1
Couch, RB1

Trials

1 trial available for rimantadine and Lung Diseases, Obstructive

ArticleYear
Rimantadine prophylaxis in children: a follow-up study.
    The Pediatric infectious disease journal, 1988, Volume: 7, Issue:6

    Topics: Adamantane; Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Metho

1988